News Hub | News Direct

Lifestyle

Beverage: Coffee/Tea/Non-Alcoholic Beverage: Spirits/Beer/Wine Casino/Gaming Fashion Food/Cooking/Baking Health & Fitness Home Goods Hospitality Leisure Activities & Hobbies Parenting Pets Photography Seniors Travel & Tourism
Article thumbnail News Release

Summer Road Trip Maintenance Guide

YourUpdateTV

Road trips are a great way to get out there and explore this summer. And while it’s certainly fun to make unexpected pit stops at roadside attractions along the way, the last thing you want to do is make an unexpected stop because of a problem with your vehicle. Recently, ASE Certified Mechanic, Audra Fordin, partnered with Chevron to discuss some simple tips to help save you time, inconvenience, and money this summer. A video accompanying this announcement is available at: Before hitting the road, remember to polish your headlights. Headlights used to be made out of glass, but nowadays they are made from plastic which can be easily oxidized from the sun, causing a haze to form over the light that can reduce your visibility. If you see cataracts starting to form on your headlights, give them a quick polish. You can find easy headlight restoration kits available at your local auto store or online. Also make sure to check your tires. If you see any bulges, tears or cracks, replace them immediately to avoid a potential blow out. Most tires typically last 3 to 5 years so if yours are in that span or older (you can check the manufacturer’s date on the side of the tire), it’s time to replace them. And of course, check your oil. If you know you’re due for an oil change, have it changed. If you’re unsure, you can always check your oil dipstick – if the oil doesn’t reach about the “add” line or is dark and not golden in color, it’s time to replace it before you leave. Audra recommends Havoline® LIFELONG Full Synthetic Motor Oil, which delivers outstanding performance at any stage in a vehicle’s life, whether you’re driving something new or something with over 75,000 miles on it. It also comes in Havoline’s recyclable Smart Change packaging, reducing plastic waste by 70% compared to traditional quart bottles. In addition, Havoline ® PRO-RSTM Renewable Full Synthetic Motor Oil, is a top-tier, renewable full synthetic motor oil that includes 25% sustainably sourced plant-based oils. It’s the best performing full synthetic oil in the Havoline portfolio and offers superior fuel economy retention to help save on fuel costs. One other great – and easy - fuel saving tip is to use Techron Complete Fuel System Cleaner. It’s a fuel additive that will deep clean and protect your entire fuel system, optimize engine performance, and maximize fuel economy to save more with every pour. All you have to do is just pour it into your gas tank once a season before you hit the road and you’re ready to go! Visit www.havoline.com or www.techronclean.com for more information and be sure to check out www.Walmart.com and select Walmart stores for Havoline and Techron products. About Audra Fordin Audra Fordin is an ASE Certified mechanic and fourth generation shop owner at Great Bear Auto in Flushing, New York. As a small business owner, PTA mom and girl scout troop leader, Audra knows how to juggle family life, run a fully staffed, successful auto repair shop and is determined to teach women across the country how to do their own automotive maintenance, which is why she’s also the founder of Women Auto Know and Drivers Auto Know, engaging and hands on workshops where drivers of all skill levels learn how to “pop open the hood and do it themselves.” Audra has made appearances on Ryan and Kelly, Rachel Ray, the Today Show, Inside Edition, and CNN, among several local news appearances, to share car care tips with millions of viewers. She also is the host of Motorweek’s Your Drive and serves on several automotive advisory boards. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

June 28, 2023 10:30 AM Eastern Daylight Time

Video
Article thumbnail News Release

Living with Myasthenia Gravis: The Rare Autoantibody Disease That Causes Muscle Weakness and Severe Fatigue

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/-FuYn9PdBdI What would you do if you began to have symptoms of drooping eyelids and difficulty speaking? A rare and unfamiliar condition that turned to a daily struggle to chew, swallow, smile, see, or even lift your arms, legs, and neck. That is what happened to Meridith O’Connor at the age of 13 and after two long years of doctor visits, she was finally diagnosed with myasthenia gravis, also known as MG. Myasthenia gravis is a chronic autoantibody condition of the nervous system that affects muscle strength and makes everyday activities like standing, blinking, swallowing, and moving your arms challenging. MG is a highly debilitating rare disease for which there currently is no cure. As many as 60,000 Americans, and 700,000 people worldwide are living with the condition. June is Myasthenia Gravis Awareness Month, which provides an opportunity for people around the world to recognize the impact of MG. On June 26th a media tour was conducted with Meridith O’Connor, Assistant Vice President of Patient Engagement, Advocacy, and Policy for the Myasthenia Gravis Foundation of America (MGFA), and Dr. Nicholas Silvestri, an associate professor of neurology at the University at Buffalo Jacobs School of Medicine and Biomedical Sciences, to learn the latest on the disease and how it affects those living with it. Approximately 85% of people living with MG experience the more extensive form of the disease, generalized myasthenia gravis (gMG). MG affects both men and women and occurs across all ages and racial and ethnic groups. However, it most commonly impacts young adult women and older men. Diagnosis is often a long, frustrating, and painful journey for patients. This is because muscle weakness is a common symptom of many disorders, and symptoms can fluctuate. Patients often face months or years of untreated symptoms before they receive an accurate diagnosis, which is why they are often diagnosed at an older age. Despite availability of treatment options, significant unmet need persists, as up to 20% of patients do not respond to existing treatments and are left with no effective therapeutic options. Research is needed to develop new treatments for those who may not respond well and/or tolerate current therapies. FOR MORE INFORMATION VISIT: IMAGINEMYMG.COM THIS MEDIA TOUR IS BROUGHT TO YOU BY THE JANSSEN PHARMACEUTICAL COMPANIES OF JOHNSON & JOHNSON. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

June 28, 2023 10:02 AM Eastern Daylight Time

Video
Article thumbnail News Release

Fresh and Fun 4th of July Party Ideas for Your Barbecue Bash

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/8tpbMSiWRsI If you’re celebrating Independence Day this year — and statistics say you probably are — your plans most likely include food. The National Retail Federation found that 86 percent of Americans plan to do something to celebrate our country’s independence, and for 61 percent of them, it means having a cookout, barbecue, or picnic. If you are hosting, or even attending, a 4th of July get together how do you prep and plan and have fresh and fun ideas. Lifestyle Expert, Bethany Braun-Silva has you covered with great ideas for what to eat and drink and how to stay healthy during your festivities. Healthier and better for you options that will delight our guests this summer Mighty Sesame Tahini is the hugely popular maker of all-natural, high-quality Squeeze and Serve Organic Tahini made with one ingredient…the highest quality sesame seeds that are sustainably sourced. The delicious, creamy texture makes this a better for you complement to dressings mon items like on summer salads, as well as for recipes, dips,meats and veggies and your favorite wraps and sandwiches. You can drizzle directly from the bottle or add it to any recipe to add 8g of plant-based protein per serving. When it comes to beverages, one that is in Bethany’s rotation is a cold-pressed juice option from Wonder Melon. Wonder Melon has the sweetness and nutritional value of watermelons, is organic, all natural and has no added sugars. It can be enjoyed right from the bottle cold, or you can enjoy as a delicious drink mix. Wonder Melon is available in three mouthwatering flavors: Watermelon Cucumber Basil, Watermelon Lemon Cayenne, and new Watermelon. Spending time outdoors and being mindful of mosquitoes The 4th of July is a holiday to be spent outdoors, so whether you’re camping, hosting a BBQ or heading to the beach, you don’t want your fun to be ruined by mosquitoes. As you’re thinking about what to buy for your vacation or party, add OFF!® Clean Feel to your list for protection from mosquitoes, ticks and biting flies. OFF!® Clean Feel is a fragrance-free, non-sticky repellent and since it’s formulated with Picaridin, it feels good on skin and won’t damage clothing. It repels mosquitoes for up to 8 hours, so you can use OFF!® Clean Feel with confidence and enjoy the holiday outdoors uninterrupted. Prevention is the best protection from mosquitoes. Bug spray is most effective when applied before mosquitoes start to bite, so you should apply it before getting to your 4th of July activity. If you are planning outdoor celebrations and travel how do you protect yourself against contaminated air Airborne Particle Blocker® is the first a nd only topical gel that prevents airborne particles from entering the nose. You apply a small amount of gel around your nasal passages, and it acts as a barrier. It blocks virus-sized particles, pollen, pollution, pet dander and dust. Available in Unscented and Cool Menthol, Naslaguard has products specific for Air Travelers, Pet Lovers, Allergy Sufferers as well as a mask spray, nasal spray and an antiseptic topical gel. The product is safe, drug-free, and non-irritating for the whole family - children, the elderly, and pregnant or nursing women. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

June 28, 2023 09:44 AM Eastern Daylight Time

Video
Article thumbnail News Release

Chill Brands Group CEO takes aim at "moral panic" around vaping

Chill Brands Group PLC

Chill Brands Group PLC (LSE:CHLL, OTCQB:CHBRF) CEO Callum Sommerton speaks to Thomas Warner from Proactive about recent additions to the product range on offer at Chill.com, the performance of the business during the first half of calendar year 2023 and his hopes for the coming months. He reiterates his commitment to launching nicotine-free vapes in the UK market, saying that "the second half of this year is all about that activation", and says Chill Brands is "proving wrong the doubters in relation to what I suggest is a moral panic around vaping that's happening in the UK at the moment." Chill is already marketing nicotine-free vapes in the US, and Sommerton says that he's already "getting great data from our US pilot stores." Contact Details UK Editorial +44 20 7989 0813 uk@proactiveinvestors.com

June 28, 2023 08:08 AM Eastern Daylight Time

Video
Article thumbnail News Release

Philadelphia’s Future Female Leaders Attend Free Construction Camp for Girls throughout Summer of 2023

NEST

Local Philadelphia-area girls entering 7 th through 12 th grade will attend a free construction camp this summer to provide real-world experience, mentorship, and education about the opportunities that exist in the construction industry, regardless of gender. The camp is called MyWIC, which stands for Mentoring young Women In Construction, and will take place in Philadelphia between Thursday, July 6 through Friday, Aug. 11. MyWIC is run by the NAWIC Philadelphia Foundation, which partnered with companies like NEST, a leading national facilities management company, and Girls Inc. of Greater Philadelphia & Southern Jersey to make it a reality. The camp strives to create a sustainable labor pool in the construction industry while exposing young women to careers they may not have previously considered. The Philadelphia Youth Network Work Ready also provides funding to cover a portion of the cost. “MyWIC is developing America’s next generation of female leaders by teaching them about the construction and skilled trades industry,” said Mary Gaffney, NAWIC Phila. Foundation President. “Females make up only about 10% of the construction industry, and there are incredible opportunities to build a career in the skilled trades. By the end of the camp, we see a tangible increase in the girls’ self-confidence, self-esteem, and overall self-image.” “The construction industry and the skilled trades offer so many opportunities for future careers that are in high demand, not only in Philadelphia but across the country,” said Rob Almond, CEO of NEST, which is based in South Jersey. “The MyWIC camp is a summer-long tradition that shows the girls the incredible career opportunities in our industries. The girls learn that construction is so much more than swinging a hammer.” The construction camp will take place at several trade locations throughout the Philadelphia area during July and August. Each day, the girls will learn about a specialty within the trades, including carpentry, sheet metal, safety training, electricians, finishing trades, steamfitters, plumbers, and retail construction. The attendees of the camp are coordinated by Girls Inc. of Greater Philadelphia & Southern Jersey. About Mentoring Young Women In Construction Mentoring young Women In Construction (MyWIC) is a free, construction industry, day camp for 7 th through 12 th -grade girls in the Philadelphia region. MyWIC is organized and run by the NAWIC Philadelphia Foundation, a 501(C)3 non-profit organization, and sponsored by various organizations throughout the Philadelphia region. About National Association of Women in Construction With more than 115 chapters across the country, the National Association of Women in Construction (NAWIC) offers its members education, support, and networking to help advance women’s careers in construction, build their technical skills, and become leaders. NAWIC’s core purpose is to strengthen and amplify the success of women in the construction industry from tradeswomen to business owners. The Philadelphia Chapter of NAWIC and the NAWIC Philadelphia Foundation are volunteer organizations. About Girls Inc. of Greater Philadelphia & Southern New Jersey Girls Inc. of Greater Philadelphia & Southern New Jersey has been serving girls and young women in the Greater Philadelphia region since 1961, originally as Teen Aid. In collaboration with schools, community partners, the juvenile justice system, shelters, corporations, and approximately 300 volunteers, we provide programs for thousands of girls and young women in the Philadelphia region’s most under-resourced communities each year. Our holistic approach recognizes that empowering girls to be successful, independent women requires that they have the tools to make healthy decisions about their bodies, receive academic enrichment, are exposed to mentors who work in a broad range of careers, have strategies to deal with bullying and violence, and parents/caregivers engaged in their success. About NEST NEST is the pioneer of the Integrated Facilities Management (IFM) industry in the United States and Canada. Founded in 1994, NEST delivers day-to-day tactical management of facilities, financial consulting, analytics, project management, and construction for major multi-site brands across North America. NEST provides 360° support 24 hours a day through one comprehensive facilities management solution that drives cost savings while maintaining an exceptional customer experience. To learn more about NEST, visit enterNEST.com or follow NEST on LinkedIn. Contact Details Eric PR & Marketing, LLC Eric Nemeth +1 602-502-2793 nemeth@ericpr.com Company Website http://www.enternest.com

June 27, 2023 12:37 PM Eastern Daylight Time

Article thumbnail News Release

OYO Celebrates 4th of July with Discounted Stays, as Bookings Expected to Touch Record Numbers

OYO

Global travel technology company OYO has announced a special offer for the upcoming Independence Day holiday as bookings are expected to clock record numbers. With the 4th of July offer, guests can avail a discount of 33% on their room bookings. This limited-time offer celebrates the spirit of the holiday and provides an opportunity for travelers to plan their getaway on a budget. The offer is applicable for stays at OYO hotels across the US till the 10th of July and for bookings made on or before 5 th of July. To redeem the offer, customers need to book their stay on the OYO app or website and enter the promo code “4THJULY”. Customers can also book by calling on +1 405-342-7056. Speaking about the upcoming holiday, Gautam Swaroop, CEO OYO International said, “This is one of the most important holidays in the country, and if recent reports are any indication, this 4 th of July travel will break all records. Recent reports indicate that approximately 50.7 million people will travel 50 miles or more from their home for the July 4th holiday, breaking the record of 49 million set in 2019. We expect increased hotel bookings within city limits and along highways, as a vast majority of Americans will be hitting the road.” OYO offers hotels access to a large base of regular customers through its app and website, and lists hotels on multiple Online Travel Agents (OTAs) to boost booking demand and revenue. OYO’s best-in-class Artificial Intelligence-enabled pricing software automatically drives the best booking prices across all channels, based on room type, seasonality and other factors, therefore, enabling such an increase in online revenues. OYO has started offering hotels the flexibility of not having to invest heavily in redoing the hotel to join the OYO platform, something that other budget hotel chains insist on. Therefore, the initial investment to join OYO is minimal. It has been focusing instead on standardizing service led components such as customer support and booking experience. The company helps ensure great experience for customers, with ease of search and a quick booking experience, highly competitive room prices as per market demand patterns, automated tools such as Artificial Intelligence powered chatbots to quickly resolve customer queries, loyalty programs and easy refund, if needed. Earlier this year OYO said that it is planning to add over 100 hotels in the US in 2023. This is nearly double the number of hotels the company added to its portfolio in 2022. OYO will focus on adding more hotels in the states of Oregon, Washington, Texas, Oklahoma, Georgia and Florida. The company also achieved a 48% growth in revenue from bookings on its own platform, such as the app, website, mobile web and call centers in Q4 2022 vs same period in 2021. OYO’s app saw highest growth with a 99% surge in revenue from bookings in Q4 2022 vs same period in 2021. The company had earlier disclosed that its app is the second most downloaded travel app with over 100 million downloads globally. About OYO: OYO is a global platform that aims to empower entrepreneurs and small businesses with hotels and homes by providing full-stack technology products and services that aim to increase revenue and ease operations; bringing easy-to-book, affordable, and trusted accommodation to customers around the world. OYO offers 40+ integrated products and solutions to patrons who operate over 168,711 hotel and home storefronts in more than 35 countries including India, Europe and Southeast Asia, as of September 30, 2022. For more information, visit www.oyorooms.com. Disclaimer: Oravel Stays Limited is proposing, subject to applicable statutory and regulatory requirements, receipt of requisite approvals, market conditions and other considerations, to make an initial public offering of its equity shares (the “Equity Shares”) and has filed the Draft Red Herring Prospectus (“DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of SEBI at www.sebi.gov.in, websites of the Stock Exchanges, i.e., BSE Limited and National Stock Exchange of India Limited at www.bseindia.com and www.nseindia.com, respectively, and is available on the websites of the Global Coordinators and Book Running Lead Managers, i.e., Kotak Mahindra Capital Company Limited, J.P. Morgan India Private Limited and Citigroup Global Markets India Private Limited at www.investmentbank.kotak.com, www.jpmipl.com and www.online.citibank.co.in/rhtm/citigroupglobalscreen1.htm; the websites of the Book Running Lead Managers, i.e., ICICI Securities Limited, Nomura Financial Advisory and Securities (India) Private Limited, JM Financial Limited and Deutsche Equities India Private Limited at www.icicisecurities.com, www.nomuraholdings.com/company/group/asia/india/index.html, www.jmfl.com and www.db.com/India, respectively. Investors should note that investment in equity shares involves a high degree of risk and for details relating to the same, refer to the Red Herring Prospectus which may be filed with the Registrar of Companies in the future, including the section titled “Risk Factors”. Potential investors should not rely on the DRHP filed with SEBI for making any investment decision. The Equity Shares offered in the Fresh Issue (as defined in the DRHP) and the Offer for Sale (as defined in the DRHP) have not been and will not be registered under the U.S. Securities Act of 1933, as amended (the “Securities Act”) and, may not be offered or sold within the United States except pursuant to an exemption from, or in a transaction not subject to, the registration requirements of the Securities Act and applicable state securities laws. Accordingly, the Equity Shares are only being offered and sold (i) within the United States only to “qualified institutional buyers” (as defined in Rule 144A under the Securities Act) in transactions exempt from, or not subject to, the registration requirements under the Securities Act, and (ii) outside the United States in offshore transactions in reliance on Regulation S under the Securities Act and pursuant to the applicable laws of the jurisdictions where those offers and sales are made. There will be no public offering of the Equity Shares in the United States. Contact Details Anupriya +91 97911 63065 anupriya.d@oyorooms.com Company Website https://www.oyorooms.com/

June 27, 2023 11:00 AM Eastern Daylight Time

Article thumbnail News Release

Tribe WOD Founders Sue Factory 14 and Razor Group, Alleging Fraud and Breach of Contract

Tribe WOD

The founders of Tribe WOD, a prominent cross-training and fitness equipment manufacturer, have filed a lawsuit against brand aggregators Factory 14 and Razor Group, citing deceit, fraud, breach of contract, unfair and deceptive trade practices, and unjust enrichment, among other offenses. The lawsuit, filed in Massachusetts Superior Court, alleges that the defendants, Factory 14 and Razor Group, failed to fulfill promises made during the acquisition of Tribe WOD. Alleged breaches of the agreement include failure to make earn-out payments as well as failing to provide access to business records – all outlined in the acquisition contract. Originating from a humble Massachusetts garage, Tribe WOD founders Alexandre Vitet and Jared Bane built their company into a $2.5 million enterprise before selling it to Factory 14, which later resold it to Razor Group. Despite promises of global expansion, enhanced marketing, access to industry experts, and potential earn-out payments, the plaintiffs argue that the defendants neglected their commitments, substantially harming the company and disregarding U.S. laws and business practices. Tribe WOD, which launched in 2019, swiftly grew to over $2.5 million in sales in just a few months, establishing strong sales channels via Amazon, Shopify, and various online platforms. This success attracted several potential buyers, with Factory 14 standing out due to its promise of multiple payments tied to Tribe WOD's annual earnings through earn-outs. The lawsuit contends that shortly after the acquisition, Factory 14 sold the assets of Tribe WOD to Razor Group, bypassing an anti-assignment provision in the original agreement. It is alleged that Factory 14 knowingly withheld information regarding this potential transaction from the plaintiffs. According to the lawsuit, Vitet and Bane had doubled revenue year-over-year and had expected to, at a minimum, match that. The lawsuit states that based on the promises made during the courtship and due diligence phase, there were immediate red flags after signing the acquisition agreement, and the situation quickly spiraled downward. Moreover, the complaint asserts that both Factory 14 and Razor Group systematically dismantled Tribe WOD, dismissing in-house creative content specialists and neglecting basic operational necessities. According to the lawsuit, Factory 14 and Razor Group failed to comply with federal and state tax, wage, and import laws and otherwise mismanaged the business financially. The lawsuit also states that the defendants had no U.S. bank account or credit card and were unable to obtain either and thus were unable to pay any of the company’s bills. The lawsuit alleges that the failure to pay basic bills led to lost revenue and the ability to serve existing customers or expand to new markets. The plaintiffs claim that their consulting agreements were prematurely terminated and allege that income from Tribe WOD was siphoned off to other businesses. The lawsuit alleges that Factory 14 and Razor Group essentially turned a thriving brand built by the founders with a rabid customer following into an Amazon seller with no identity, and loaded with unnecessary fees. The lawsuit seeks compensatory and multiple damages and injunctive relief, compelling the defendants to provide accurate and complete financial data. Interestingly, Razor Group faces a similar lawsuit in Texas, as it is being sued by the founders of Kettlebell Kings in a case with similar allegations. On its website, Razor Group states that it is trusted by leading investors Blackrock, Victory Park Capital, and Fortress among others. The Tribe WOD lawsuit was filed in Massachusetts Superior Court by Garage Sweat, LLC f/k/a Tribe Wod, LLC, Jared Bane, and Alexandre Vitet against Factory 14 UK Acquisition IV, Ltd., Razor Group GMBH, and Razor Group USA, LLC. This case has been accepted into and will be litigated in the Business Litigation Session, a business-focused sub-department of the Massachusetts Superior Court sited in Boston, Suffolk County, Massachusetts. The lawsuit can be downloaded here and at LawsuitPressRelease.com. -end- Source: Garage Sweat, LLC f/k/a Tribe WOD, LLC Contact Details LawsuitPressRelease.com John P. David +1 888-859-6637 john@LawsuitPressRelease.com

June 26, 2023 11:01 AM Eastern Daylight Time

Article thumbnail News Release

Spiceology and Over-The-Fire-Cooking Expert Derek Wolf Expand Line of Beer-Infused Spice Blends

Spiceology

Spiceology, the fast-growing spice company known for its innovative signature blends, has once again teamed up with over-the-fire-cooking expert and social media phenomenon, Derek Wolf ( @overthefirecooking ), to create new beer-infused barbeque blends. Packaged in the fan-favorite resealable beer cans, the Spiceology x Derek Wolf Beer-Infused Rub Collection now includes a total of ten flavor-packed rubs, all infused with perfectly paired beers. Now available for purchase, this new four-pack takes consumers on a road trip around the United States to celebrate some of Wolf’s favorite styles of barbeque, including odes to Memphis, East Carolina and West Texas. “Since first launching the beer-infused six-pack with Spiceology back in 2020, we both knew we wanted to expand the beer can line,” said Derek Wolf, Over The Fire Cooking. “Beer and barbeque have always gone together, and these blends offer new ways to experiment with those flavors. For these new blends, we specifically formulated each one with a protein in mind.” These beer-infused blends can be purchased as a four-pack or as individual cans, with plastic lids included: Sticky Bourbon Brown Ale ($14.95): Memphis-style with burnt sugar sweetness, bourbon notes, and a tiny amount of heat for balance. The blend is designed for pork but is also ideal for baked beans, sauces, grilled veggies, and compound butter. Sweet Carolina Blonde ($14.95): Inspired by eastern Carolina’s Mop Sauce, this beer-infused blend packs tang, sweet and heat all in one. Designed for pork and poultry, this blend also works for chicken, seafood, pasta, rice, and marinades. Smoked Garlic Jalapeño Lager ($14.95): Inspired by West Texas’ love of chile-based heat. This beer-infused flavor twist on a classic salt and pepper blend is made for beef, but works perfectly with pasta salad, dressings, marinades, roasted veggies, and more. Big Bad BBQ Ale ($14.95): An all-purpose BBQ blend with all of Derek’s favorite flavor profiles. This blend is made for anything and everything, especially smash burgers, beef, chicken, pork, vegetables, and seafood. “The original six-pack of beer-infused blends we formulated with Derek quickly became one of our most popular products and gift sets,” said Chef Tony Reed, Executive Director of Culinary. “For this round, Derek wanted classic BBQ rubs with his personal twist, and the addition of ingredients like cinnamon, cocoa, and of course, beer, brought these classic-style blends to the next level.” The blends can be found on Spiceology.com and are available in individual beer cans or as a set of all four. For more information, see here. ABOUT SPICEOLOGY Founded in 2013, Spiceology is on a mission to inspire experimentation and share in the joy of cooking and eating. The chef-owned and operated spice company’s ‘Periodic Table of Flavor’ spotlights innovative blends and over 300 ingredients that are ground fresh and shipped fresh. With Signature Blends like Greek Freak and Smoky Honey Habanero that have become pantry and counter staples in both professional and home cook kitchens around the world, Spiceology is at the heart of the kitchen for all who love food. Spiceology‘s ingredients and blends can be found in the aisles of retailers large and small, in the pantries of hundreds of thousands of home cooks, and in the kitchens of some of the world’s greatest chefs. Contact Details Spiceology Cassidy Levine +1 908-770-7880 cassidy@spiceology.com Company Website https://spiceology.com/

June 26, 2023 08:00 AM Eastern Daylight Time

Image
Article thumbnail News Release

Pancreatic Cancer Trials & New Treatments Receiving Increased Funding as Incidences of Cancer Grows

STORM Partners

FinancialNewsMedia.com News Commentary - Pancreatic cancer is one of the leading causes of cancer death globally. The increasing incidence of this cancer across the U.S. and other parts of the world is one of the factors driving the need for the drugs used in the treatment. The increase in the geriatric population is one factor driving the pancreatic cancer treatment market growth. The incidence is significantly higher in the geriatric population above 65 years of age compared to other types of cancers. The increase in the number of patients suffering from the condition has increased the demand for the drugs used in treatment. A report from Fortune Business Insights said that this factor will be driving the growth for the next several years. The report projected that the global pancreatic cancer treatment market size was valued at USD 2.48 billion in 2022 and will grow to USD 6.85 billion by 2029, exhibiting a CAGR of 15.7% during the forecast period. The report continued: “Companies engaged in manufacturing cancer drugs have increased their focus on R&D activities to develop new drugs for pancreatic cancer treatment. Additionally, the companies operating in the market have received approval from several regulatory bodies, such as the U.S. Food and Drug Administration (FDA), the Medicines and Healthcare Products Regulatory Agency (MHRA) (U.K.), among others, thereby propelling the growth of the market. Moreover, new testing technologies are being adopted by hospitals and diagnostic centers to diagnose cancer. The increase in the diagnosis rates is driving the demand for drugs, thereby providing opportunities for the players.” Active biotech and pharma companies in the markets this week include Oncolytics Biotech ® Inc. (ONCY – ONC.TSX), Sotera Health Company (NASDAQ: SHC), Centessa Pharmaceuticals plc (NASDAQ: CNTA), Bristol Myers Squibb (NYSE: BMY), Gilead Company (NASDAQ: GILD). Fortune Business Insights continued: “Shifting the focus of key players in extensive R&D activities to develop new drugs and an increase in funding for cancer research led to the development of new drugs for treatment. Additionally, several pharmaceutical companies are involved in clinical trials to develop new drugs and explore the potential of the molecule to treat the disease. It concluded: “Thus, with the increased funding for R&D activities, companies are focused on developing new drugs, thereby contributing to the overall rise in demand for drugs for pancreatic type of cancer treatment through 2029.” Oncolytics Biotech ® Inc. (ONCY - ONC) BREAKING NEWS: Oncolytics Biotech’s® Pelareorep Selected for Inclusion in Precision PromiseSM Pivotal Phase 3 Platform Trial – Adaptive clinical trial designed to accelerate registration pathways for pancreatic cancer therapies and expected to reduce cost of a Phase 3 study for pelareorep by ~50% compared to a traditional trial If successful, new clinical study expected to support approval of pelareorep in combination with a checkpoint inhibitor, gemcitabine, and nab-paclitaxel in first-line metastatic pancreatic cancer Data presented at SITC 2022 showed a near tripling of overall response rate for pelareorep + gemcitabine + nab-paclitaxel + a PD-L1 inhibitor compared to historical control trials Oncolytics Biotech ® (trading on the NASDAQ under the Symbol ONCY and the TSX exchange under ONC) today announced pelareorep has been selected for inclusion as a new investigational treatment in Precision PromiseSM, an innovative adaptive Phase 3 clinical trial. The Precision Promise study is designed to evaluate pelareorep in combination with a checkpoint inhibitor and the chemotherapeutic agents gemcitabine and nab-paclitaxel. If successful, the clinical study is expected to support approval of the studied combination as a treatment for first-line metastatic pancreatic ductal adenocarcinoma (PDAC). Precision Promise has a primary endpoint of overall survival and can include multiple investigational treatments as well as control arms evaluating: (1) gemcitabine plus nab-paclitaxel or (2) mFOLFIRINOX. Each investigational therapy is subject to pre-specified interim analyses prior to proceeding to the registrational portion of the trial. This design, which was developed with guidance from the U.S. Food and Drug Administration, minimizes the number of participants needed to generate licensure-enabling data, thereby accelerating late-stage development by up to two years and reducing costs compared to non-platform trials. “We are delighted at being selected by the Precision Promise panel of experts,” said Dr. Matt Coffey, President, and Chief Executive Officer of Oncolytics Biotech. “Our next step is to engage with stakeholders to finalize the protocol for Precision Promise’s pelareorep-containing investigational treatment so that we can enter into this study. We are thrilled to have the opportunity to leverage Precision Promise, which we expect will allow us to reduce the time and costs needed to reach a potential approval.” Julie Fleshman, JD, MBA, President and CEO of PanCAN commented, “With a five-year survival rate of 12%, pancreatic cancer patients cannot afford to wait for new treatment options. This urgent unmet need was the driving inspiration behind the Precision Promise platform trial, which was designed specifically to identify, accelerate, and de-risk the development of promising pancreatic cancer treatments. We are thrilled to be bringing pelareorep into Precision Promise as a new investigational therapy to study against the current standard of care.” Dr. Thomas Heineman, Chief Medical Officer of Oncolytics Biotech, commented, “Prior trials in pancreatic cancer show pelareorep-based combinations outperforming historical controls on key metrics such as one and two-year survival and objective response rate. In addition, mechanistic data from these studies highlight how pelareorep’s immunologic mechanism of action allows it to synergize with chemotherapy and checkpoint inhibition in this indication. I look forward to working with the Precision Promise team of investigators to seek to confirm the therapeutic value of pelareorep in a randomized setting so that we can potentially provide pancreatic cancer patients with a new treatment option.” CONTINUED …Read this full press release and more news for ONCY at: https://www.financialnewsmedia.com/news-oncy/ Other recent breast cancer developments in the biotech industry of note include: Sotera Health Company (NASDAQ: SHC) recently announced that the opt-in process for the January 2023 settlements of ethylene oxide claims against Sterigenics in the Circuit Court of Cook County, Illinois is complete and Sterigenics has elected to proceed with the settlements. 879 of the 882 claimants eligible to participate in the settlement program have opted in. The settling claimants and Sterigenics will now request that the Circuit Court enter an order confirming that these are good-faith settlements under the Illinois Contribution Among Joint Tortfeasors Act. The settlement funds will be released from escrow for disbursement to the settling claimants ten days after the Court enters the anticipated good-faith determination and their claims against Sterigenics will subsequently be dismissed with prejudice. The lawsuits of the three claimants who opted out of the settlement will proceed to pretrial discovery pursuant to a schedule to be set by the Circuit Court. Centessa Pharmaceuticals plc (NASDAQ: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for patients, recently announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to SerpinPC, an investigational novel inhibitor of activated protein C (APC) being developed for the treatment of hemophilia B, with or without inhibitors. "We are pleased with the FDA’s decision to grant Fast Track designation for SerpinPC as we continue to advance the PRESent registrational studies for SerpinPC in hemophilia B,” said Saurabh Saha MD PhD, Chief Executive Officer of Centessa. “This designation is important recognition of SerpinPC’s novel mechanism of action and underscores the critical need for new treatment options for persons with hemophilia B. We believe SerpinPC has the potential to be a first-in-class subcutaneously administered therapy with a differentiated safety profile for persons with hemophilia B, subject to review and approval.” Bristol Myers Squibb (NYSE: BMY) announced the first disclosure of primary analysis results from two pivotal studies, TRANSCEND FL, an open-label, global, multicenter, Phase 2, single-arm study evaluating Breyanzi (lisocabtagene maraleucel; liso-cel) in patients with relapsed or refractory follicular lymphoma (FL) and the relapsed or refractory mantle cell lymphoma (MCL) cohort of TRANSCEND NHL 001, an open-label, multicenter, Phase 1, single-arm, seamless-design study evaluating Breyanzi. These data were presented in late-breaking oral presentations at the 2023 International Conference on Malignant Lymphoma (ICML) on Saturday, June 17. "With Breyanzi, we’re dedicated to delivering a CAR T cell therapy with a differentiated profile to transform outcomes for some of the most difficult-to-treat lymphomas," said Anne Kerber, senior vice president, head of Cell Therapy Development, Bristol Myers Squibb. "Based on results from TRANSCEND FL and TRANSCEND NHL 001, Breyanzi continues to demonstrate the ability to elicit significant deep and durable responses alongside a manageable safety profile, potentially addressing areas of high unmet need and reinforcing our commitment to advancing innovative solutions for the broadest array of hematologic malignancies of any CD19-directed CAR T cell therapy." Kite Pharma, Inc., a Gilead Company (NASDAQ: GILD) announced that the Marketing Authorization in Japan for Yescarta® (axicabtagene ciloleucel), a chimeric antigen receptor (CAR) T-cell therapy, has been transferred from Daiichi Sankyo Co., Ltd. to Gilead Sciences K.K., the Japan subsidiary of Gilead Sciences, Inc. This follows the announcement made by Daiichi Sankyo and Kite Pharma, Inc. in December 2022 about changes to their initial 2017 partnership whereby Daiichi Sankyo obtained the Marketing Authorization for Yescarta®. With this completion of the Marketing Authorization transfer, the sales and promotion activities of Yescarta® in Japan now will be managed by the Kite Cell Therapy Business Unit of Gilead Sciences K.K. DISCLAIMER: FN Media Group LLC (FNM), which owns and operates FinancialNewsMedia.com and MarketNewsUpdates.com, is a third party publisher and news dissemination service provider, which disseminates electronic information through multiple online media channels. FNM is NOT affiliated in any manner with any company mentioned herein. FNM and its affiliated companies are a news dissemination solutions provider and are NOT a registered broker/dealer/analyst/adviser, holds no investment licenses and may NOT sell, offer to sell or offer to buy any security. FNM's market updates, news alerts and corporate profiles are NOT a solicitation or recommendation to buy, sell or hold securities. The material in this release is intended to be strictly informational and is NEVER to be construed or interpreted as research material. All readers are strongly urged to perform research and due diligence on their own and consult a licensed financial professional before considering any level of investing in stocks. All material included herein is republished content and details which were previously disseminated by the companies mentioned in this release. FNM is not liable for any investment decisions by its readers or subscribers. Investors are cautioned that they may lose all or a portion of their investment when investing in stocks. For current services performed FNM was compensated forty nine hundred dollars for news coverage of the current press releases issued by Oncolytics Biotech ® Inc. by a non-affiliated third party. FNM HOLDS NO SHARES OF ANY COMPANY NAMED IN THIS RELEASE. This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company's annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and FNM undertakes no obligation to update such statements. SOURCE Financialnewsmedia.com Contact Details Financial News Media Media Contact +1 561-325-8757 editor@financialnewsmedia.com

June 23, 2023 01:09 PM Eastern Daylight Time

1 ... 7273747576 ... 283